Blog Archives

Blog

Platforms for collaboration between sponsors and CROs: 5 ways CROs can scale efficiently while maximizing validation assurance

Platforms for collaboration between sponsors and CROs provide validation assurance & improve sponsor outcomes with…

CertaraMarch 31, 2026

Blog

Data Fabrics in Pharma: Connecting Data for Better Decisions

Learn how a data fabric in pharma connects siloed systems. Explore the benefits of data…

CertaraMarch 31, 2026

Blog Knowledge Base

Where Did the 80-125% Bioequivalence Criteria Come From?

Discover what bioequivalence criteria mean, why the 80-125% bioequivalence range is used, and how custom…

CertaraMarch 27, 2026

Blog

Shaping the Future of Medical Writing: Key Themes for 2026

Five key themes and their implications for leaders shaping their Medical Writing strategy for 2026

CertaraMarch 26, 2026

Blog

Interactive Global Value Dossiers: turning evidence into market access impact

Learn how an interactive global value dossier improves stakeholder engagement and streamlines value dossier preparation…

CertaraMarch 25, 2026

Blog

Why the Most Important Phase 3 Decisions Should Be Made Before Phase 3

Learn how advanced modeling for reimbursement strategy using MBMA and QSP strengthens payer evidence and…

CertaraMarch 24, 2026

Blog

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

Learn how regulatory expectations in clinical pharmacology are evolving and how to build a strategy…

CertaraMarch 24, 2026

Blog

What are Common Bioequivalence Study Mistakes?

Learn about the most common bioequivalence study mistakes drug developers make and the differences between…

CertaraMarch 20, 2026

Blog

The future of payer engagement in pharma: rethinking how value is communicated

A detailed analysis of strategies for payer engagement in pharma and how digital payer engagement…

CertaraMarch 19, 2026

Blog Knowledge Base

What is GLP (Good Laboratory Practice)?

Read this blog to understand GLP (Good Laboratory Practice) and associated QA audits, and proper…

CertaraMarch 18, 2026

Blog

Platforms for collaboration between sponsors and CROs: 5 ways CROs can scale efficiently while maximizing validation assurance

Data Fabrics in Pharma: Connecting Data for Better Decisions

Where Did the 80-125% Bioequivalence Criteria Come From?

Shaping the Future of Medical Writing: Key Themes for 2026

Interactive Global Value Dossiers: turning evidence into market access impact

Why the Most Important Phase 3 Decisions Should Be Made Before Phase 3

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

What are Common Bioequivalence Study Mistakes?

The future of payer engagement in pharma: rethinking how value is communicated

What is GLP (Good Laboratory Practice)?

Newsletter sign up

Quick links

Solutions

Contact